Clinical Trials Logo

Gynecologic Cancer clinical trials

View clinical trials related to Gynecologic Cancer.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05776693 Enrolling by invitation - Gynecologic Cancer Clinical Trials

Relationships Among Physical and Psychological Status, Social Support, Resource Utilization, Supportive Care Needs in Patients With Gynecological Cancer

Start date: November 24, 2022
Phase:
Study type: Observational

With the advancement of medical treatments and under the trend of prolonging the survival rate of gynecological cancer patients, the use of social resources and the need for supportive care are particularly important! In the past, studies on patients with gynecological cancer focused on the relation between physical and mental symptoms, intimate relationships, social support, and quality of life. There were few studies on the relationship between social support, resource utilization, and supportive care needs for this group of patients. Therefore, this study research will be conducted on these topics. The results of the study can confirm the current situation of gynecological cancer patients using social resources and the related factors that affect their supportive care needs, and can provide important empirical data for future social resource services and international research design content.

NCT ID: NCT05763667 Enrolling by invitation - Post Operative Pain Clinical Trials

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Start date: January 1, 2024
Phase: Phase 3
Study type: Interventional

Modern postoperative pain management aims to optimizing pain relief while minimizing opiate usage. While opiates are effective for pain relief, they result in common adverse effects such as nausea, constipation, and urinary retention, and most importantly present a long-term risk of abuse and dependency. Commonly used approaches include non-opiate pain medications such as acetominophen and non-steroidal anti-inflammatory agents, as well as regional nerve blocks such as epidurals. The transversus abdominis plane (TAP) block is a fascial plane block performed by injecting local anesthetic into the plane superficial to the transversus abdominis muscle where the anterior rami of the spinal nerves course to provide sensory innervation to the abdominal wall. The injections are generally placed either subcostally or at the midaxillary line bilaterally. The TAP block has been shown to be effective in reducing pain scores and opiate usage in some randomized studies but not others in patients undergoing various abdominal surgeries. There is great variation in method of administration, sites injected, and local anesthetics used, which may in part account for the heterogeneity of trial results.

NCT ID: NCT05629065 Enrolling by invitation - Breast Cancer Clinical Trials

Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)

(PATH-SIC)
Start date: November 28, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to increase serious illness conversations (SICs) about patients goals and preferences regarding their healthcare between patients with cancer and their oncology clinicians and improved care provided near the end of life.

NCT ID: NCT05318625 Enrolling by invitation - Ovarian Cancer Clinical Trials

A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery.

Start date: January 10, 2023
Phase: N/A
Study type: Interventional

Precision Robotics' Sirius Robotic Flexible Endoscopic System is a new fully integrated compact 3D laparoscopic camera system with a disposable single-use flexible tip that can change its viewing direction. A Prospective Study to Evaluate the Clinical Performance and Safety of the SIRIUS Endoscope System in Laparoscopic Gynecological Surgery. The study is a single-arm prospective study to evaluate the Performance and Safety of the SIRIUS Endoscope System.

NCT ID: NCT04707937 Enrolling by invitation - Gynecologic Cancer Clinical Trials

Evaluation of a Brachytherapy Discharge Education Program to Improve Patient Care

BrachDEP
Start date: August 19, 2020
Phase: N/A
Study type: Interventional

Although brachytherapy is an effective treatment modality for gynecological cancer, a significant proportion of patients develop late treatment-related vaginal toxicity, negatively impacting their quality of life and limiting recurrent disease detection by preventing adequate clinical examination during the post-treatment surveillance period. Consistent with the literature, results from a study at Princess Margaret revealed that current vaginal toxicity management education and training may be inadequate. The investigators seek to implement and evaluate a new online brachytherapy discharge education program (BrachDEP) to support patient engagement in self-management.